EMFAT
MRNS

Emerald Mutual Fund Advisers Trust’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-40,726
Closed -$1.42M – 271
2015
Q1 		$1.42M Hold
40,726
– – 0.12% 147
2014
Q4 		$1.72M Buy
40,726
+4,611
+13% +$134K 0.15% 127
2014
Q3 		$935K Buy
+36,115
New +$1.12M 0.09% 153

Other funds holding MRNS

CPV
Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's MRNS Position: Q2 2015 in Review

Emerald Mutual Fund Advisers Trust sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2015, closing a stake of 40,726 shares — an estimated $1.42M sold.

Emerald Mutual Fund Advisers Trust first reported a position in MRNS in Q3 2014 and held it in 3 quarters. The position peaked at $1.72M in Q4 2014. 27 funds tracked by Wall St. Rank hold MRNS as of Q2 2015.

  • Emerald Mutual Fund Advisers Trust reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2015 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 40,726 Marinus Pharmaceuticals, Inc shares in Q2 2015, an estimated $1.42M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Marinus Pharmaceuticals, Inc in Q3 2014 and held it in 3 quarters.
  • Emerald Mutual Fund Advisers Trust's Marinus Pharmaceuticals, Inc position peaked at $1.72M in Q4 2014.
  • 27 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2015.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2015, filed 28 Jul 2015.